News

Nvidia's (NASDAQ: NVDA) business has surged since the start of last year, fueled by a boom in artificial intelligence (AI). The company's years of expertise in graphics processing units (GPUs) gave

Some investors might have been worried only a few weeks ago that the bull market was screeching to a halt. Those concerns should now be largely alleviated.

When you plan to hold stocks long-term

Shares of Patterson Companies (NASDAQ: PDCO) were plunging 15.1% as of 11:09 a.m. ET on Wednesday. The steep decline came after the dental and animal health company announced its fiscal 2025

Eli Lilly's (NYSE: LLY) insatiable hunger to squeeze even more money out of its best-selling therapies is starting to look downright impressive. With its research and clinical groups firing on all

News from a deep-pocketed rival put the hurt on biotech Viking Therapeutics's (NASDAQ: VKTX) stock on Tuesday. Said rival seems determined to dominate a very hot therapeutic area these days, and it

Shares of beleaguered drug store and pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) fell 8.4% on Tuesday as of 3:22 p.m. ET.

The reason for the drop today appears to be twofold: One, Pfizer

When most people think of the cruise industry, companies like Royal Caribbean (NYSE: RCL) and Carnival Cruise Lines (NYSE: CCL) come to mind. However, unique cruise operator Viking River Cruises

With Pfizer (NYSE: PFE) stock badly underperforming the market over the past three years, falling by 32% while the market rose by close to the same amount, the last thing shareholders want to hear

Medtronic (NYSE: MDT) posted first-quarter earnings (for the period ended on June 30) that exceeded the average of Wall Street estimates. The results were strong enough for the medical technologies

SpaceX has been a remarkable success over the last 15 years. It brought the space flight industry in the United States -- really, around the world -- back to life and inspired plenty of copycats

Exciting trends are sweeping through the biotech industry. One of them is the race to develop breakthrough weight loss medicines, an area that is projected to grow by leaps and bounds through the

Shares of Viking Therapeutics (NASDAQ: VKTX), a clinical-stage drugmaker working on metabolic treatments, have tripled in value this year. Despite the huge run-up, analysts who follow the company

Which income investors want to buy stocks with dividends likely to decline and iffy businesses? None. Instead, income investors want practically unstoppable dividend stocks.

Three Motley Fool

Tilray Brands (NASDAQ: TLRY) is no stranger to acquisitions. That has been a key part of its growth strategy and a way for it to expand its operations over the years. That has allowed it to grow its

Bill Ackman of Pershing Square Holdings and Andreas Halvorsen of Viking Global Investors are two highly regarded billionaire-level investment managers. In the second quarter, their companies added

BlackRock oversees more than $10 trillion in client money, making it the largest asset manager in the world. Around $3.3 trillion of that is parked in its iShares subsidiary, which operates over

It's been a great year for Novavax (NASDAQ: NVAX). The biotech is up by 150% since January. However, analysts see even more upside for the vaccine maker. The consensus estimate of $20 a share

Dividend stocks can be a great source of cash flow for your portfolio. You don't need to settle for stocks that pay just a few percentage points, either. Some fairly safe, high-yielding stocks pay

Clinical-stage biotech AnaptysBio (NASDAQ: ANAB) has recently been something of a standout, at least on the stock exchange. According to data compiled by S&P Global Market Intelligence, the

Novo Nordisk (NYSE: NVO) is enjoying one of the best seasons in its history. Two of the company's drugs, Ozempic and Wegovy, have become household names. Novo's sales and profits are soaring. So is